Scanning NSE · BSE · NYSE · NASDAQ

Inovio Pharmaceuticals, Inc. - (INO) share price

Inovio Pharmaceuticals, Inc. - (NASDAQ:INO) last traded at $1.22, down 16.21% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $0.13B and a 52-week range of $0.56 to $2.72.

Key facts for Inovio Pharmaceuticals, Inc. -
ExchangeNASDAQ
CurrencyUSD
Last price$1.22
1-day move-16.21%
52-week range$0.56 - $2.72
Market cap$0.13B
From 52-week high-55.30%
Volume vs average3.9x
Falling Shares risk score74/100 (CRITICAL)
CountryUnited States

Frequently asked questions

Why is Inovio Pharmaceuticals, Inc. - falling today?

Inovio Pharmaceuticals, Inc. - (NASDAQ:INO) is down 16.21% at its latest quote and trades 55.3% below its 52-week high, on volume 3.9x its average. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.

What is the Inovio Pharmaceuticals, Inc. - share price today?

Inovio Pharmaceuticals, Inc. - (NASDAQ:INO) last traded at $1.22, a -16.21% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.

What is the 52-week range of Inovio Pharmaceuticals, Inc. -?

Inovio Pharmaceuticals, Inc. -'s 52-week low is $0.56 and its 52-week high is $2.72; the shares trade 55.3% below the high.

What is the market cap of Inovio Pharmaceuticals, Inc. -?

Inovio Pharmaceuticals, Inc. - has a market capitalisation of about $0.13B at the latest price.

What are the risks of investing in Inovio Pharmaceuticals, Inc. -?

Falling Shares Intelligence rates Inovio Pharmaceuticals, Inc. - 74/100 (CRITICAL) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.

Data is compiled from public exchange feeds and may be delayed. Not investment advice.

Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com